🇺🇸 FDA
Patent

US 6162620

Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor

expired A61KA61K39/00

Quick answer

US patent 6162620 (Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor) held by Cogent Partners, LP expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Cogent Partners, LP
Grant date
Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K39/00